Cargando…

Highly frequent PIK3CA amplification is associated with poor prognosis in gastric cancer

BACKGROUND: The phosphoinositide 3-kinase (PI3K)/Akt pathway plays a fundamental role in cell proliferation and survival in human tumorigenesis, including gastric cancer. PIK3CA mutations and amplification are two major causes of overactivation of this pathway in human cancers. However, until this w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shi, Jing, Yao, Demao, Liu, Wei, Wang, Na, Lv, Hongjun, Zhang, Guanjun, Ji, Meiju, Xu, Li, He, Nongyue, Shi, Bingyin, Hou, Peng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3299648/ https://www.ncbi.nlm.nih.gov/pubmed/22292935 http://dx.doi.org/10.1186/1471-2407-12-50

Ejemplares similares

Frequent Gene Amplification Predicts Poor Prognosis in Gastric Cancer
por: Shi, Jing, et al.
Publicado: (2012)

Highly frequent promoter methylation and PIK3CA amplification in non-small cell lung cancer (NSCLC)
por: Ji, Meiju, et al.
Publicado: (2011)

Increased expression of EHF via gene amplification contributes to the activation of HER family signaling and associates with poor survival in gastric cancer
por: Shi, Jing, et al.
Publicado: (2016)

Frequent amplification of AIB1, a critical oncogene modulating major signaling pathways, is associated with poor survival in gastric cancer
por: Shi, Jing, et al.
Publicado: (2015)

Metallothionein 1G functions as a tumor suppressor in thyroid cancer through modulating the PI3K/Akt signaling pathway
por: Fu, Jiao, et al.
Publicado: (2013)

PIK3CA gene mutation associated with poor prognosis of lung adenocarcinoma
por: Zhang, Lina, et al.
Publicado: (2013)

Increased copy number of mitochondrial DNA predicts poor prognosis of esophageal squamous cell carcinoma
por: Li, Heng, et al.
Publicado: (2018)

Downregulation of miR203 induces overexpression of PIK3CA and predicts poor prognosis of gastric cancer patients
por: Liang, Min, et al.
Publicado: (2015)

PIK3CA amplification is associated with poor prognosis among patients with curatively resected esophageal squamous cell carcinoma
por: Kim, Hyo Song, et al.
Publicado: (2016)

PIK3CA and KRAS Amplification in Esophageal Adenocarcinoma and their Impact on the Inflammatory Tumor Microenvironment and Prognosis
por: Essakly, Ahlem, et al.
Publicado: (2019)

Variable copy number of mitochondrial DNA (mtDNA) predicts worse prognosis in advanced gastric cancer patients
por: Zhang, Guanjun, et al.
Publicado: (2013)

Increased expression of NAF1 contributes to malignant phenotypes of glioma cells through promoting protein synthesis and associates with poor patient survival
por: Wei, Jing, et al.
Publicado: (2019)

Copy Number Amplification of the PIK3CA Gene Is Associated with Poor Prognosis in Non-lymph node metastatic Head and Neck Squamous Cell Carcinoma
por: Suda, Toshihito, et al.
Publicado: (2012)

Mutations of PIK3CA in gastric adenocarcinoma
por: Li, Vivian Sze Wing, et al.
Publicado: (2005)

PIK3CA exon 20 mutations are associated with poor prognosis in breast cancer patients
por: Mangone, Flavia R., et al.
Publicado: (2012)

Prognostic implications of PIK3CA amplification in curatively resected liposarcoma
por: Kim, Joo Hoon, et al.
Publicado: (2016)

PIK3CA Mutations Frequently Coexist with EGFR/KRAS Mutations in Non-Small Cell Lung Cancer and Suggest Poor Prognosis in EGFR/KRAS Wildtype Subgroup
por: Wang, Lei, et al.
Publicado: (2014)

Mutational analysis of anal cancers demonstrates frequent PIK3CA mutations associated with poor outcome after salvage abdominoperineal resection
por: Cacheux, Wulfran, et al.
Publicado: (2016)

Mutation and genomic amplification of the PIK3CA proto-oncogene in pituitary adenomas
por: Murat, C.B., et al.
Publicado: (2012)

Oncogenic PIK3CA induces centrosome amplification and tolerance to genome doubling
por: Berenjeno, Inma M., et al.
Publicado: (2017)

AIB1 Genomic Amplification Predicts Poor Clinical Outcomes in Female Glioma Patients
por: Chen, Lihong, et al.
Publicado: (2016)

Single Nucleotide Polymorphism rs17849071 G/T in the PIK3CA Gene Is Inversely Associated with Follicular Thyroid Cancer and PIK3CA Amplification
por: Xing, Jeffrey C., et al.
Publicado: (2012)

TERT promoter mutations and long telomere length predict poor survival and radiotherapy resistance in gliomas
por: Gao, Ke, et al.
Publicado: (2015)

PIK3CA Mutations Frequently Coexist with RAS and BRAF Mutations in Patients with Advanced Cancers
por: Janku, Filip, et al.
Publicado: (2011)

Frequent PIK3CA mutations in eutopic endometrium of patients with ovarian clear cell carcinoma
por: Murakami, Kosuke, et al.
Publicado: (2021)

Allelic expression imbalance of PIK3CA mutations is frequent in breast cancer and prognostically significant
por: Correia, Lizelle, et al.
Publicado: (2022)

Association between PIK3CA alteration and prognosis of gastric cancer patients: a meta-analysis
por: Li, Hua, et al.
Publicado: (2018)

Association of promoter methylation with histologic type and pleural indentation in non-small cell lung cancer (NSCLC)
por: Ji, Meiju, et al.
Publicado: (2011)

Mutations in PI3K/AKT pathway genes and amplifications of PIK3CA are associated with patterns of recurrence in gastric cancers
por: Fang, Wen-Liang, et al.
Publicado: (2015)

PIK3CA amplification and PTEN loss in diffused large B-cell lymphoma
por: Cui, Wenli, et al.
Publicado: (2017)

Clinicopathological Characteristics of PIK3CA Mutation and Amplification in Korean Patients with Breast Cancers
por: Lee, Moo-Hyun, et al.
Publicado: (2020)

Cardia Gastric Cancer Is Associated With Increased PIK3CA Amplifications and HER2 Expression Than Noncardia Gastric Cancer According to Lauren Classification
por: Pai, Shih-Min, et al.
Publicado: (2021)

PIK3CA mutations are frequently observed in BRCAX but not BRCA2 -associated male breast cancer
por: Deb, Siddhartha, et al.
Publicado: (2013)

Low copy number of mitochondrial DNA (mtDNA) predicts worse prognosis in early-stage laryngeal cancer patients
por: Dang, Siwen, et al.
Publicado: (2014)

Combined treatment with a gastric inhibitory polypeptide receptor antagonist and a peptidyl peptidase-4 inhibitor improves metabolic abnormalities in diabetic mice
por: Yang, Fei, et al.
Publicado: (2021)

PIK3CA Mutation Analysis in Iranian Patients with Gastric Cancer
por: Iranpour, Mostafa, et al.
Publicado: (2019)

Clinicopathological Significance of Elevated PIK3CA Expression in Gastric Cancer
por: Jang, Si-Hyong, et al.
Publicado: (2016)

Carcinogenesis of PIK3CA
por: German, Sidra, et al.
Publicado: (2013)

Non-hotspot PIK3CA mutations are more frequent in CLOVES than in common or combined lymphatic malformations
por: Brouillard, Pascal, et al.
Publicado: (2021)

Genomic copy number gains of ErbB family members predict poor clinical outcomes in glioma patients
por: Liu, Rui, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_l30t3j4icmjsev62sv9e8c33kc